Home|Journals|Articles by Year|Audio Abstracts
 

Original Research

Egypt. J. Exp. Biol. (Zoo.). 2012; 8(1): 155-159


STUDY THE PREVALENCE OF ARTHRITIC MANIFESTATIONS IN PATIENTS WITH BRUCELLOSIS

Nidhal Abdul Mohaimen Farouk K. Hassan Nazik Minsour.




Abstract

The present study was designed to study the prevalence of rheumatological manifestations in patients with Brucella infection. One hundred seven patients of suspected human brucellosis attending Al-Naumaniya hospital were included in this study. The majority of patients were farmers (90.6%); the prevalence of brucellar arthritis was 42.99%. Diagnosis of brucellosis was based on clinical manifestations together with the positive serological test which included Rose Bengal agglutination test (RBAT), tube agglutination test (TAT). Tests were confirmed with blood culture. Blood cultures were positive for B. melitensis biotype 1 and 2 in 14 cases and for B. abortus biotype 1 in 3 cases. Auxiliary tests were performed to confirm brucellosis and brucellar arthritis. These tests included antistreptolysin-O agglutination (ASOT), Widal test, antinuclear antibodies, rheumatoid factor (RF) and acute phase protein (CRP). ASOT was found to be positive in 21 patients (19.62%) and Widal test in 17 patients (15.8%) with brucellosis. RF, ANA, and CRP were positive in 23.9%, 2.17%, and 43.47%, respectively in patients with brucellar arthritis.

Key words: Brucella, Arthritis, Rose Bengaltest, Serological tests






Full-text options


Share this Article


Online Article Submission
• ejmanager.com




ejPort - eJManager.com
Refer & Earn
JournalList
About BiblioMed
License Information
Terms & Conditions
Privacy Policy
Contact Us

The articles in Bibliomed are open access articles licensed under Creative Commons Attribution 4.0 International License (CC BY), which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.